Foxtale has raised $30 million in Series C funding, led by KOSÉ Corporation, to enhance its D2C skincare brand's growth and expand its product offerings in the booming Indian skincare market.
Information on the Target
Foxtale is an innovative direct-to-consumer (D2C) skincare brand founded in 2021 by Romita Mazumdar, focused on transforming the skincare landscape for Indian women. By centering consumer narratives and employing modern science and technology, Foxtale develops high-performing and safe skincare formulas tailored to the evolving emotional and lifestyle demands of its target audience. The brand has rapidly emerged as a trusted name in the Indian beauty market, achieving significant customer satisfaction with a portfolio of 20 distinct skincare products.
In its latest Series C funding round, Foxtale successfully raised $30 million (approximately INR 250 Crore), attracting participation from notable investors, including the Japanese multinational KOSÉ Corporation, Panthera Growth Partners, Z47, and Kae Capital. This funding reflects the strong confidence investors have in Foxtale's vision of revolutionizing skincare through science-backed innovations and consumer-centric strategies.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in India
India's skincare market is witnessing unprecedented growth, driven by rising disposable incomes, heightened awareness of personal care, and a growing inclination towards premium products. As urbanization continues to rise, more consumers are now seekin
Similar Deals
Tata Consumer Products Ltd. → Capital Foods and Organic India
2024
KOSÉ Corporation
invested in
Foxtale
in 2025
in a Other deal
Disclosed details
Transaction Size: $30M